A community‐based, cross‐sectional study of hr HPV DNA self‐sampling‐based cervical cancer screening in rural Karnataka, India
Open accessAbstract
Objective: To examine the feasibility of implementing a high‐risk HPV (hr HPV) DNA‐based screening program for cervical cancer and the prevalence of hr HPV DNA‐positive women in a community setting in rural India. Methods: A cross‐sectional study was conducted at the community level in the Hunsur taluk of the Mysore district from January to August 2016. Cervical cancer screening was conducted with self‐collected vaginal samples that were analyzed using the Hybrid Capture 2 (HC 2) assay (Qiagen, USA). Results: The majority of participants were aged 30–39 years, with no formal schooling, from a lower caste, and lived below an annual household income of US$1499. After group health education and one‐on‐one counseling, a total of 473 women underwent self‐sampling. Of these, 36 (7.6%) were positive for hr HPV and only 24 (66.6%) underwent follow‐up diagnostic triaging. Cancer was detected in two women, who were referred to appropriate healthcare facilities for further treatment. Conclusion: Implementation of hr HPV DNA‐based screening tests using self‐sampling can be feasible in rural settings in India. However, substantial resources are required for providing health education and one‐on‐one counseling to inform asymptomatic women about the benefits of testing and, more importantly, to improve compliance with follow‐up.
AI snapshot
Written from the paper’s full text.
TL;DR
This community-based cross-sectional study in rural Karnataka found that hrHPV DNA self-sampling-based cervical cancer screening was feasible, with 36 of 473 women (7.6%) testing hrHPV-positive. Follow-up compliance was 66.6%, and two cancers were detected, highlighting the need for substantial resources for education, counseling, and follow-up.
Key findings
- Among 473 women aged 30–59 years who underwent self-sampling, 36 (7.6%) were positive for hrHPV DNA using the Hybrid Capture 2 assay.
- Of the 36 screen-positive women, 24 (66.6%) underwent follow-up diagnostic triaging; 9 (25%) were unwilling to undergo pelvic examination because they lacked symptoms, and 3 (8.3%) could not be traced after migration.
- Among the 24 followed up, 5 (20.8%) tested positive on VIA; cervical smear results were negative in 19 (79.2%), atypical glandular cells in 3 (12.5%), low-grade lesion in 1, and high-grade lesion in 1; 9 (37.5%) were referred to tertiary care. Cancer was detected in two women.
- The majority of participants were aged 30–39 years, had no formal schooling, belonged to a lower caste, and lived in households earning approximately US$1499 (₹104,930) annually.
Methods
- Cross-sectional community-based study conducted in Hunsur taluk, Mysore district, Karnataka, from January to August 2016, with follow-up until December 2017; 25 villages were selected based on road accessibility and availability of a community or primary healthcare center with toilet facilities and running water.
- Eligible women were aged 30–59 years, not pregnant, and without a history of cancer or hysterectomy; after group health education and one-on-one counseling, 473 women provided self-collected vaginal samples analyzed with the HC2 assay for 13 high-risk HPV types.
- Screen-positive women were invited to the PHRII clinic for VIA and cervical smears according to WHO guidelines, with referral to tertiary care if either test was positive; demographics were described and analyses conducted in IBM SPSS v. 21.
Limitations
- The paper states that the cross-sectional design captures prevalence at only a single point in time, is prone to non-response bias, and has limited generalizability to all of India; it also notes that HC2 is considered less sensitive and specific when used on self-collected samples.
- The paper reports that follow-up compliance was approximately 66.6%, lower than the 78% reported in a primary healthcare center study, and that the most common reason for loss to follow-up was unwillingness to undergo pelvic examination when asymptomatic.
- The text makes evident additional implementation challenges: study staff invested up to 16 additional months in education and counseling for follow-up, and at three community sites women did not attend screening clinics after hearing complaints of pain and discomfort.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
4 of 15 cited sources checked · 2 supported · 0 flagged · accuracy not yet measured
- Premisecitation
A systematic review of studies that included the option for self-sampling has shown improved participation among women who do not routinely attend screening programs.
“Furthermore, a systematic review of studies that included the option for self-sampling has shown improved participation among women who do not routinely attend screening programs [11].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] Racey CS, Diana RW, and Dionne G, Self-collected HPV Testing Improves Participation in Cervical Cancer Screening: A Systematic Review and Meta-analysis. Canadian Journal of Public Health / Revue Canadienne de Santé Publique, 2013 104(2): p. e159– e166. 23618210 PMC6973997 source
- Findingown data
Of the 36 screen-positive women, 24 (66.6%) underwent follow-up diagnostic triaging.
“Of these, 36 (7.6%) were positive for hrHPV and only 24 (66.6%) underwent follow-up diagnostic triaging.”
- Also stated in: § RESULTS · plain
“The remaining 24 (66.6%) women were invited and, in some cases, provided with transport to the PHRII clinic (located on average 18 miles from the villages) for follow-up.”
Quote in the paperNot a substantial claim - Also stated in: § RESULTS · plain
- Findingown data
Of the 473 women, 36 (7.6%) tested positive for hrHPV DNA in self-collected vaginal swab samples.
“Of these, 36 (7.6%) were positive for hrHPV and only 24 (66.6%) underwent follow-up diagnostic triaging.”
- Also stated in: § RESULTS · plain
“Of the 473 women, 36 (7.6%) tested positive for presence of hrHPV DNA in the self-collected vaginal swab samples.”
- Also stated in: § DISCUSSION · plain
“Of the 473 women recruited in the study, 36 women (7.6%) tested positive for the presence of hrHPV DNA in the self-collected vaginal specimens.”
Quote in the paperSubstantial claim- Rests on an assumption: The 473 women recruited are representative of the Hunsur taluk population.
- Also stated in: § RESULTS · plain
- Findingown data
Nine women (37.5%) who tested positive for VIA and/or had abnormal cervical smear test results were referred to the tertiary care center for further diagnostic follow-up and management.
“Nine women (37.5%) who tested positive for VIA and/or an had abnormal cervical smear test results were referred to the tertiary care center for further diagnostic follow-up and management.”
Quote in the paperNot a substantial claim - Findingown data
Three (8.3%) screen-positive women could not be traced in the villages because they had migrated away for farm work.
“Three (8.3%) women could not be traced in the villages as they had since migrated away from the villages for farm work, despite three separate attempts to reach them over the one-year follow-up period.”
Quote in the paperNot a substantial claim
- Findingown data
The most common reason for loss to follow-up was the woman's unwillingness to undergo pelvic examination as a follow-up test when they were not experiencing any symptoms.
“The most common reason for loss to follow-up was the woman’s unwillingness to undergo pelvic examination as a follow-up test when they were not experiencing any symptoms.”
Quote in the paperNot a substantial claim - Findingown data
Of the 36 screen-positive women, nine (25%) were unwilling to undergo a pelvic examination due to a lack of symptoms despite one-on-one counseling.
“Of the 36 screen-positive women, nine (25%) women were unwilling to undergo a pelvic examination due to a lack of symptoms despite one-on-one counseling by the physician and the nurses on the study team.”
Quote in the paperNot a substantial claim - Findingown data
Five (20.8%) of the 24 followed-up women tested positive for VIA.
“Five (20.8%) women tested positive for VIA.”
Quote in the paperNot a substantial claim - Findingnone given
At three of the community sites, women did not attend screening clinics because they had heard that women had complained about pain and discomfort after undergoing the screening test.
“At three of the community sites, women did not attend screening clinics because they had heard that women had complained about pain and discomfort after undergoing the screening test.”
Quote in the paperNot a substantial claim - Premisecitation
hrHPV DNA-based screening tests provide 60%-70% greater effectiveness in detecting invasive cervical carcinomas compared with cytology in several large-scale randomized trials.
“Of these, high-risk HPV (hrHPV) DNA-based screening tests have been shown to provide 60%–70% greater effectiveness in detecting invasive cervical carcinomas compared with cytology in several large-scale randomized trials [3].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Ronco G,, Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The Lancet. 2014; 383(9916): p. 524– 532. 24192252 source
- Interpretationown data
Implementation of hrHPV DNA-based screening tests using self-sampling can be feasible in rural settings in India.
“Implementation of hrHPV DNA-based screening tests using self-sampling can be feasible in rural settings in India.”
Quote in the paperSubstantial claim- Rests on an assumption: The impact of screening on mortality reduction requires high screening coverage and that screen-positive women receive appropriate diagnostic and treatment services.
- Premisecitation
In a cluster randomized trial in India, a single round of hrHPV testing was associated with a significant reduction in advanced cervical cancers and deaths due to cervical cancer.
“In a cluster randomized trial in India, a single round of hrHPV testing was associated with a significant reduction in the number of advanced cervical cancers and deaths due to cervical cancer [4].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Sankaranarayanan R,, HPV screening for cervical cancer in rural India. New England Journal of Medicine, 2009 360(14): p. 1385– 1394. 19339719 source
- Study design and conductreasoning
The prevalence noted in this study is representative of only a single point in time among the participants.
“Although recruitment took place over a six-month period, the prevalence noted in this study is representative of only a single point in time among the participants.”
Quote in the paperNot a substantial claim
- May combine two claims. 17
- Classified as probably not a substantial claim. 19
- The quote only partly states this claim. 1
May combine two claims.
PremisecitationStudies from India have identified barriers to cervical cancer screening on several socioecological levels, including lack of knowledge, personal disbelief in prevention of cancer, lack of care-seeking when asymptomatic, lack of money for treatment, and reduced access to healthcare services.
“Studies from India have identified barriers on several socioecological levels such as lack of knowledge, personal disbelief in prevention of cancer, lack of care-seeking when asymptomatic, lack of money for treatment, and reduced access to healthcare services [6–8].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [6] Nene B,, Determinants of women s participation in cervical cancer screening trial, Maharashtra, India. Bulletin of the World Health Organization, 2007 85(4): p. 264– 272. 17546307 PMC2636321 source
The Introduction and Discussion identify lack of knowledge, unfamiliarity with prevention, and economic and geographic barriers to cervical cancer screening. The paper does not specifically identify failure to seek care when asymptomatic or lack of money for treatment as barriers; the Discussion says treatment in this study was free and economic barriers were unlikely to explain reduced follow-up. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [7] Aswathy S,, Cervical cancer screening: Current knowledge & practice among women in a rural population of Kerala, India. The Indian Journal of Medical Research, 2012 136(2): p. 205– 210. 22960886 PMC3461731
- cites [8] Adsul P,, Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review. Cancer Epidemiol, 2017 49: p. 161– 174. 28704717 PMC5571735 source
The Introduction reports low public awareness and few screening facilities in India, while Results > Implementation barriers and facilitators reports reluctance to visit a clinic when asymptomatic. These passages support several listed barriers, but the copy does not identify disbelief in cancer prevention or lack of money for treatment as barriers. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationThe self-collection option offers the distinct advantage of moving primary screening activities from the clinic into the community.
“The self-collection option also offers the distinct advantage of moving primary screening activities from the clinic into the community [12].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [12] Gravitt PE,, Looking ahead: a case for HPV testing of self-sampled vaginal specimens as a cervical cancer screening strategy. International journal of cancer. Journal international du cancer, 2011 129(3): p. 517– 527. 21384341 PMC3782104 source
May combine two claims.
Findingown dataCancer was detected in two women, who were referred to appropriate healthcare facilities for further treatment.
“Cancer was detected in two women, who were referred to appropriate healthcare facilities for further treatment.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe majority of participants were aged 30-39 years, had no formal schooling, belonged to a lower caste, and lived in a household with an annual income of approximately US$1499.
“The majority of participants were aged 30–39 years, with no formal schooling, from a lower caste, and lived below an annual household income of US$1499.”
- Also stated in: § RESULTS · plain
“As shown in Table 1, the majority of the participants were aged 30–39 years, with no formal schooling, belonging to a lower caste (considered as a socioeconomic indicator), and lived in a household that earned an annual household income of approximately US$1499 (₹104,930).”
Quote in the paperNot a substantial claim- Also stated in: § RESULTS · plain
The quote only partly states this claim.
Findingown dataA total of 473 women aged 30-59 years, not pregnant, and without a history of cancer or hysterectomy underwent self-sampling.
“After group health education and one-on-one counseling, a total of 473 women underwent self-sampling.”
- Also stated in: § RESULTS · plain
“A total of 473 women aged 30–59 years, not pregnant, and without a history of cancer or hysterectomy were included in the study.”
Quote in the paperSubstantial claim- Also stated in: § RESULTS · plain
May combine two claims.
Findingown dataOf the 24 followed-up women, 19 (79.2%) tested negative on cervical smear, three (12.5%) had atypical glandular cells, one had low-grade and one had high-grade lesion.
“A total of 19 women (79.2%) tested negative on cervical smear, three (12.5%) had atypical glandular cells, one had low-grade and one had high-grade lesion reported on the cervical smear tests.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe study staff invested up to 16 additional months in conducting health education sessions and counseling women to complete their follow-up visits.
“The study staff invested up to 16 additional months in conducting health education sessions and counseling women to complete their follow-up visits.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationCompliance with follow-up in this study was approximately 66.6%, which was lower compared with a study reporting follow-up rates of 78% when screening was implemented in primary healthcare centers.
“Compliance with follow-up in our study was approximately 66.6%, which was lower compared with a study reporting follow-up rates of 78% when screening was implemented in primary healthcare centers [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Mittal S,, HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India. Cancer Causes & Control, 2016 27(3): p. 351– 358. 26712612 source
- Rests on an assumption: The impact of screening on mortality reduction requires high screening coverage and that screen-positive women receive appropriate diagnostic and treatment services.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenFrom anecdotal evidence, several women sought second opinions from gynecologists practicing in the private sector, often resulting in a preference for hysterectomies.
“From anecdotal evidence, several of these women sought second opinions from gynecologists practicing in the private sector, often resulting in a preference for hysterectomies.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationA persistent HPV infection causes most cases of cervical cancer.
“A persistent infection with HPV causes most cases of cervical cancer; for many women who have an existing HPV infection or do not have access to HPV vaccination, improved screening for early detection and treatment remains the best option for reducing the cervical cancer burden [2].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Gravitt PE and Rositch AF, HPV self-testing and cervical cancer screening coverage. The Lancet Oncology, 2014 15(2): p. 128– 129. 24433681 source
Probably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataSubstantial resources are required for providing health education and one-on-one counseling to inform asymptomatic women about the benefits of testing and to improve compliance with follow-up.
“However, substantial resources are required for providing health education and one-on-one counseling to inform asymptomatic women about the benefits of testing and, more importantly, to improve compliance with follow-up.”
Quote in the paperNot a substantial claim- Rests on an assumption: The impact of screening on mortality reduction requires high screening coverage and that screen-positive women receive appropriate diagnostic and treatment services.
May combine two claims.
PremisecitationThe Hybrid Capture 2 assay is based on signal amplification techniques and considered less sensitive and specific when used on self-collected samples.
“The Hybrid Capture 2 assay is based on signal amplification techniques and considered less sensitive and specific when used on self-collected samples [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Arbyn M,, Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. The lancet oncology, 2014 15(2): p. 172– 183. 24433684 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll study materials, including the consent form, were translated into Kannada and pilot tested with a small group of women from the same community before use.
“Before being used in the study, all study materials, including the consent form, were translated into the local language of Kannada and pilot tested with a small group of women from the same community.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThis study is one of the few from India that used self-collection with the Hybrid Capture 2 assay in a community-based rural setting.
“In summary, this study is one of the few from India that used self-collection with the Hybrid Capture 2 assay in a community-based rural setting.”
Quote in the paperNot a substantial claim- Rests on an assumption: This demonstration study is one of the first attempts at studying the feasibility of conducting a screening program in rural India using hrHPV DNA tests as a primary screening strategy.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningImplementation of a molecular test for cervical cancer screening can increase the opportunities for cervical cancer screening in communities where it is needed the most.
“Implementation of a molecular test for cervical cancer screening can increase the opportunities for cervical cancer screening in communities where it is needed the most.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenEnsuring follow-up of women who were hrHPV-positive was the most challenging aspect of the study and required considerable resources, including time.
“Ensuring follow-up of women who were hrHPV-positive, however, was the most challenging aspect of the study and required considerable resources, including time.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataOvercoming the challenge of women not attending due to pain/discomfort took several additional hours of counseling and resulted in modifications of health education materials and approach.
“Overcoming this challenge took several additional hours of counseling and resulted in modifications of our health education materials and approach.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenInvolving laboratory personnel in the study team was instrumental in specimen collection and transportation to the lab for testing.
“Involving laboratory personnel in the study team was instrumental in specimen collection and transportation to the lab for testing.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFor hrHPV DNA testing, self-collected vaginal samples are an acceptable strategy and have shown comparable sensitivity and specificity to clinician-collected samples.
“For hrHPV DNA testing, self-collected vaginal samples are an acceptable strategy and have shown comparable sensitivity and specificity to clinician-collected samples [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Arbyn M,, Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. The lancet oncology, 2014 15(2): p. 172– 183. 24433684 source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenA cross-sectional study design is prone to a non-response bias, in that participants consenting to participate may be different from the ones who do not participate.
“A cross-sectional study design is also prone to a non-response bias, in that participants consenting to participate may be different from the ones who do not participate.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningThe study estimated a sample size of 368 for a prevalence study with finite population correction at 5% precision, 95% confidence interval, unknown prevalence 50%, population 8400, and with 20% oversampling final sample size 450.
“Using this information, we estimated a sample size for a prevalence study with a finite population correction as follows: at a 5% precision level, 95% confidence interval, an unknown prevalence of HPV infection at 50% for a population of 8 400, the estimated sample size was 368. With 20% oversampling for missing data, we calculated the final sample size to be 450.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenQuality control procedures per the manufacturer's instructions for the equipment and kits were followed.
“Quality control procedures per the manufacturer’s instructions for the equipment and the kits were followed.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationWomen in low-resource settings find pelvic exams to be embarrassing, painful, and uncomfortable and therefore prefer the self-sampling option.
“There is evidence that women in low-resource settings find pelvic exams to be embarrassing, painful, and uncomfortable; therefore, they prefer the self-sampling option [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Dzuba IG,, The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med, 2002 11(3): p. 265– 75. 11988136 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenStudy team members used the teach-back method to check women's understanding.
“Study team members used the teach-back method to check women’s understanding.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenPrior training and knowledge of community logistics helped effective functioning of the screening.
“Prior training and knowledge of community logistics helped effective functioning of the screening.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe hrHPV DNA test has been considered a very cost-effective option for low- and middle-income countries and is generally considered feasible if all screen-positive women receive treatment.
“The hrHPV DNA test has been considered a very cost-effective option for low- and middle-income countries and is generally considered feasible if all screen-positive women receive treatment [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Denny L,, Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. The Lancet, 2017 389(10071): p. 861– 870. 27814963 source
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenUptake of screening is only the first step in the process.
“Uptake of screening, however, is only the first step in the process.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenThis work has limited generalizability and cannot be considered as representative for all of India.
“Furthermore, this work has limited generalizability and cannot be considered as representative for all of India.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe pathology laboratory used the 2001 Bethesda system for reporting results of cervical cytology and followed standard quality control procedures per the National Accreditation Board for Testing and Calibration Laboratories.
“The pathology laboratory used the 2001 Bethesda system for reporting results of cervical cytology and followed standard quality control procedures per the National Accreditation Board for Testing and Calibration Laboratories [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Solomon D,, The 2001 Bethesda System: terminology for reporting results of cervical cytology. Jama, 2002 287(16): p. 2114– 9. 11966386 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe staff physician and nurses had been trained in performing VIA and cervical smears previously and had been delivering these services in the community for the previous eight years.
“The staff physician and nurses had been trained in performing VIA and cervical smears previously and had been delivering these services in the community for the previous eight years.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
PremisecitationThe option of self-sampling may be essential to improving the effectiveness of the program in hard-to-reach populations.
“The option of self-sampling may be essential to improving the effectiveness of the program in hard-to-reach populations [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Lazcano-Ponce E,, Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): A community-based randomised controlled trial. The Lancet, 2011 378(9806): p. 1868– 1873. 22051739 source
The paper relies on this without support.
The impact of screening on mortality reduction requires high screening coverage and that screen-positive women receive appropriate diagnostic and treatment services.
“The impact of screening on mortality reduction is contingent on achieving high screening coverage and ensuring that screen-positive women receive appropriate diagnostic and treatment services.”
The paper relies on this without support.
There are limited studies that have implemented hrHPV testing using self-sampling in a community-based setting in India.
“However, there are limited studies that have implemented hrHPV testing using self-sampling in a community-based setting in India.”
The paper relies on this without support.
This demonstration study is one of the first attempts at studying the feasibility of conducting a screening program in rural India using hrHPV DNA tests as a primary screening strategy.
“Despite these limitations, this demonstration study was one of the first attempts at studying the feasibility of conducting a screening program in rural India using hrHPV DNA tests as a primary screening strategy.”
The paper relies on this without support.
Radical hysterectomies are overtreatment for cervical cancer patients with low-volume disease.
“This is an important consideration since radical hysterectomies have been regarded as overtreatment for cervical cancer patients with low-volume disease.”
The paper relies on this without support.
The 473 women recruited are representative of the Hunsur taluk population.
“This study is a cross-sectional, descriptive study that used a large sample representative of the Hunsur taluk population for estimating the prevalence of hrHPV in rural Indian women.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Our findings align with global evidence suggesting self-sampling reduces logistical burdens in rural areas.
“While specific comprehensive follow-up data between self-sampling and nurse-assisted methods were not segregated, our findings align with global evidence suggesting self-sampling reduces logistical burdens in rural areas.26,28,29”
From Integrating a “see-and-treat” approach with opportunistic human papilloma virus deoxyribonucleic acid (HPV DNA) based cervical cancer screening in India: a retrospective cross-sectional study (2026) · cites this paper as [29]
The Introduction (page unavailable) says self-collection moves primary screening from the clinic into the community, and the Discussion says it may improve access for hard-to-reach populations. That supports a potential reduction in the burden of reaching a clinic, but the paper does not establish an overall reduction in logistical burdens; its Discussion describes follow-up as resource-intensive and challenging. (LLM, conf=0.84)
Experimental — accuracy not yet measuredThis study is one of the few studies that examined the usefulness of self-sampled swabs for cervical cancer screening in rural India.
“This is also one of the few studies that examined the usefulness of self-sampled swabs for cervical cancer screening in rural India (A Peedicayil et al., 2016; Adsul et al., 2019).”
From Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women (2021) · cites this paper as Adsul et al., 2019
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766 · see citing works
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104 · see citing works
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810 · see citing works
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278 · see citing works
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,149 · see citing works
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976 · see citing works
The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology
Solomon, D., Davey, D. D., Kurman, R. J., Moriarty, A. T., O’Connor, D., Prey, M. U., Raab, S. S., Sherman, M. E., Wilbur, D. C., & Wright, T. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200208000-00015 · Cited by 822 · see citing works
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674 · see citing works
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Arbyn, M., Snijders, P. J. F., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Kocjan, B. J., & Poljak, M. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.015 · Cited by 275 · see citing works
Denny, L., de Sanjose, S., Mutebi, M., Anderson, B. O., Kim, J., Jeronimo, J., Herrero, R., Yeates, K., Ginsburg, O., & Sankaranarayanan, R. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31795-0 · Cited by 246 · see citing works
Racey, C. S., Withrow, D. R., & Gesink, D. (2013) · Canadian Journal of Public Health · doi:10.1007/bf03405681 · Cited by 232 · see citing works
Lazcano-Ponce, E., Lorincz, A. T., Cruz-Valdez, A., Salmerón, J., Uribe, P., Velasco-Mondragón, E., Nevarez, P. H., Acosta, R. D., & Hernández-Avila, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61522-5 · Cited by 230 · see citing works
Dzuba, I. G., Díaz, E. Y., Allen, B., Leonard, Y. F., Lazcano Ponce, E. C., Shah, K. V., Bishai, D., Lorincz, A., Ferris, D., Turnbull, B., et al. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902753668466 · Cited by 208 · see citing works
(2003) · Cited by 184 · see citing works
Determinants of women's participation in cervical cancer screening trail, Maharashtra, India
Nene, B. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.031195 · Cited by 154 · see citing works
(2012) · PubMed Central · Cited by 139 · see citing works
Gravitt, P. E., Belinson, J. L., Salmeron, J., & Shah, K. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.25974 · Cited by 106 · see citing works
Adsul, P., Manjunath, N., Srinivas, V., Arun, A., & Madhivanan, P. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.06.008 · Cited by 63 · see citing works
Self-citationCareHPV cervical cancer screening demonstration in a rural population of north India
Labani, S., Asthana, S., Sodhani, P., Gupta, S. K., Bhambhani, S., Pooja, B., Lim, J., & Jerónimo, J. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.03.006 · Cited by 40 · see citing works
Mittal, S., Mandal, R., Banerjee, D., Das, P., Ghosh, I., Panda, C., Biswas, J., & Basu, P. (2016) · Cancer Causes & Control · doi:10.1007/s10552-015-0708-z · Cited by 23 · see citing works
HPV self-testing and cervical cancer screening coverage
Gravitt, P. E., & Rositch, A. F. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70605-3 · Cited by 19 · see citing works
Community Prevalence of Human Papillomavirus by Self-Collected Samples in South India
Peedicayil, A., Abraham, P., Prasad, J., Jeyaseelan, L., Abraham, S., Kurian, S., Gravitt, P., & Shah, K. V. (2016) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-016-0045-5 · Cited by 17 · see citing works
Considerations for HPV primary screening in lower-middle income countries
Maza, M., & Gage, J. C. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2016.12.029 · Cited by 13 · see citing works
ENGAGING THE COMMUNITY IN HEALTH RESEARCH IN INDIA
Wells, K. J., Preuss, C. V., Pathak, Y. V., et al. (2012) · Technology & Innovation · doi:10.3727/194982412x13292321140886 · Cited by 11 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- World Health Organization, 2013, WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention
Cited by
Sorted by citations
Hategeka, C., Adu, P., Desloge, A., Marten, R., Shao, R., Tian, M., Wei, T., & Kruk, M. E. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004055 · Cited by 50 · see citing works
Madhivanan, P., Nishimura, H., Ravi, K., Pope, B., Coudray, M., Arun, A., Krupp, K., Jayakrishna, P., & Srinivas, V. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.3.971 · Cited by 31 · see citing works
Self-citationBuilding Capacity for Global Cancer Research: Existing Opportunities and Future Directions
Sivaram, S., Perkins, S. N., He, M., Ginsburg, E., Dominguez, G., Vedham, V., Katz, F. N., Parascandola, M. J., Bögler, O., & Gopal, S. (2021) · Journal of Cancer Education · doi:10.1007/s13187-021-02043-w · Cited by 25 · see citing works
Hariprasad, R., John, A., & Abdulkader, R. S. (2023) · JCO Global Oncology · doi:10.1200/go.22.00401 · Cited by 20 · see citing works
Prevalence and correlates of metabolic syndrome among rural women in Mysore, India
Krupp, K., Adsul, P., Wilcox, M. L., et al. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.09.015 · Cited by 18 · see citing works
Self-citationOommen, A. M., Isaac, R., Paul, B., Weller, D., Finkel, M. L., Thomas, A., Ram, T. S., H. R., P., Cherian, A. G., Thomas, V., et al. (2024) · PLOS ONE · doi:10.1371/journal.pone.0301385 · Cited by 18 · see citing works
Kuriakose, S., Sabeena, S., Binesh, D., Abdulmajeed, J., Ravishankar, N., Ramachandran, A., Vijaykumar, B., & Ameen, N. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13116 · Cited by 19 · see citing works
Creagh, N. S., Boyd, L. A. P., Bavor, C., Zammit, C., Saunders, T., Oommen, A. M., Rankin, N. M., Brotherton, J. M. L., & Nightingale, C. E. (2023) · JCO Global Oncology · doi:10.1200/go.22.00297 · Cited by 17 · see citing works
Colling, A. M., Creagh, N. S., Gogia, N., Wyatt, K., Zammit, C. M., Brotherton, J. M. L., & Nightingale, C. E. (2024) · Health Expectations · doi:10.1111/hex.13961 · Cited by 15 · see citing works
Implementation strategies of cervical cancer screening in South Asia: A systematic review
Sabeena, S., Ravishankar, N., & Kalpana, M. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15366 · Cited by 10 · see citing works
“24,28,30,33,34,36,38,39,41 An increase in HPV DNA testing in self-collected vaginal samples was observed in the last 5 years.”
Oommen, A. M., Ashfaq, M., Cherian, A. G., Colling, A. M., Ramírez, A. T., Saunders, T., Singarayar, P., Thomas, V., Thomas, A., Marcus, T. A., et al. (2024) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2024.100513 · Cited by 9 · see citing works
Cancer research in South Asian Association for Regional Cooperation (SAARC) countries
Huq, M. S., Acharya, S. C., Gautam, M., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00518-7 · Cited by 7 · see citing works
Adsul, P., Hariprasad, R., Lott, B. E., et al. (2022) · Ethnicity & Disease · doi:10.18865/ed.32.4.269 · Cited by 7 · see citing works
Self-citationPanta, S., Rajaram, S., Heda, A., Bhadoria, A. S., Kalita, D., Chawla, L., & Chaturvedi, J. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.2.653 · Cited by 6 · see citing works
“For HR-HPV DNA testing, self-collected vaginal samples are an acceptable strategy and have shown comparable sensitivity and specificity to clinician-collected samples [6].”
BackgroundMadhunapantula, S., Srinivas, V., Nishimura, H., et al. (2021) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_162_19 · Cited by 6 · see citing works
Self-citationAdsul, P., de Cortina, S. H., Pramathesh, R., Jayakrishna, P., Srinivas, V., Nethan, S. T., Dhanasekaran, K., Hariprasad, R., & Madhivanan, P. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000570 · Cited by 5 · see citing works
Self-citationAdanu, R. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13024 · Cited by 4 · see citing works
Oommen, A. M., Basu, P. S., Cherian, A. G., Zomawia, E., Manoharan, R., Pricilla, R. A., Viswanathan, V., Oldenburg, B. F., Subramanian, S., Hawkes, D. J., et al. (2023) · Implementation Science Communications · doi:10.1186/s43058-023-00436-0 · Cited by 3 · see citing works
Adhikari, I., Kataria, I., Bhandari, P., Siddiqui, M., Basu, P., Abraham, P., Man, I., & Baussano, I. (2026) · Archives of Public Health · doi:10.1186/s13690-026-01916-0 · Cited by 1 · see citing works
Sarma, P., Barmon, D., Kumar, A., Kataki, A., Sarma, A., Baruah, U., Kakoti, L., Barman, D., & Sharma, R. (2024) · Cancer Reports · doi:10.1002/cnr2.70097 · Cited by 2 · see citing works
Patel, S. K., Singh, N., Jamwal, A., et al. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.7.2427 · Cited by 1 · see citing works
“Self-sampled vaginal swabs are being used in screening programs at different centres but their limitations like improper technique, non-cooperation further add to the limited implementation in the rural population (Adsul et al., 2019).”
MethodComment on Self-Sampling Methodology Impression for Cervical Cancer Screening
Keebayoon, A., & Wiwanitkit, V. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.5.1449 · Cited by 1 · see citing works
Rao, S., Chhabra, M., Kudkuli, J., Toraskar, M., Nath, A. G., Prakash, D., Srivastava, S., Imo Singh, W., Chandrasekharan, M., Oswal, K., et al. (2026) · AJOG Global Reports · doi:10.1016/j.xagr.2026.100678
Gearing up for implementation of self-sampled HPV-DNA screening test for cervical cancer in India
Kant, L. (2023) · Current Medicine Research and Practice · doi:10.4103/cmrp.cmrp_75_23
- Authors
- Adsul, P., Srinivas, V., Gowda, S., Nayaka, S., Pramathesh, R., Chandrappa, K., Khan, A., Jayakrishna, P., & Madhivanan, P.
- Affiliations
- Florida International University (US)
- Public Health Research Institute Of India (IN)
- University of Arizona (US)
- Corresponding author
- Adsul, Prajakta
- Venue
- International Journal of Gynecology & Obstetrics
- Publisher
- Wiley
- Published
- 2019-05-30
- Volume
- 146
- Issue
- 2
- Pages
- 170-176
- ISSN
- 0020-6695 (ISSN-L)
- 0020-7292
- 1879-3479
- PMC
- PMC6620767
- OpenAlex
- W2943985639
- Cited by
- 23
- References
- 24
- Citations by year
- 2026: 2 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- Locations
- International Journal of Gynecology & Obstetrics (publishedVersion, public-domain)
- PubMed (publishedVersion)
- UA Campus Repository (The University of Arizona) (acceptedVersion, public-domain)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- high-risk HPV DNA testing, cervical cancer screening, self-collected vaginal samples, rural women, screening feasibility, HPV prevalence, health education and counseling, low-income women, Karnataka
- MeSH terms
- Adult, Uterine Cervical Neoplasms, Cross-Sectional Studies, DNA, Viral, Female, Humans, India, Mass Screening, Middle Aged, Pregnancy, Surveys and Questionnaires, Vaginal Smears, Prevalence, Papillomavirus Infections, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-16.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-16.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review